{"DataElement":{"publicId":"2182637","version":"1","preferredName":"Antigen Testing Name","preferredDefinition":"Name(s) of the actual antigens used in antigen or skin testing (delayed hypersensitivity testing).","longName":"ATGN_TST_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2182629","version":"1","preferredName":"Antigen Testing","preferredDefinition":"Testing of a patient/participant to measure immune status, using a variety of antigens.  Commonly referred to as skin testing or Delayed Hypersensitivity Testing.","longName":"ATGN_TST","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2612313","version":"1","preferredName":"Antigen","preferredDefinition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","longName":"C268","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antigen","conceptCode":"C268","definition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BA59451-882D-704C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-14","endDate":null,"createdBy":"UMLLOADER_CANANOLAB","dateCreated":"2007-03-14","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2181597","version":"1","preferredName":"Testing","preferredDefinition":"A procedure for critical evaluation.","longName":"Testing","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Testing","conceptCode":"C0039593","definition":"A procedure for critical evaluation.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4A6A07C-554A-25A1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-02","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D751C8E1-8263-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Updated to use the more commonly used OC Antigen based on C268 concept. dbw Mar-5-2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182630","version":"1","preferredName":"Antigen Testing Text Name","preferredDefinition":"Text names for the substance used in Antigen or skin testing.","longName":"ATGN_TST_TXT_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Mumps","valueDescription":"Mumps","ValueMeaning":{"publicId":"2569055","version":"1","preferredName":"Mumps","longName":"2569055","preferredDefinition":"An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mumps","conceptCode":"C29888","definition":"A contagious viral infection caused by the mumps virus. Symptoms include swollen and tender parotid glands, fever, muscle aches and fatigue. Due to vaccination programs, mumps has become a rare disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DACC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-05","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D751C8E1-826E-1B6B-E034-0003BA12F5E7","beginDate":"2004-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-05","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Histoplasmin","valueDescription":"Histoplasmin","ValueMeaning":{"publicId":"2569059","version":"1","preferredName":"Histoplasmin","longName":"2569059","preferredDefinition":"No value exists","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DAD0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D751C8E1-8279-1B6B-E034-0003BA12F5E7","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Candida albicans","valueDescription":"Candida albicans","ValueMeaning":{"publicId":"2567463","version":"1","preferredName":"Candida albicans","longName":"2567463","preferredDefinition":"A species of diploid fungus in the phylum Ascomycota which is capable of mating but not of meiosis, and is a causal agent of opportunistic oral and genital infections in humans.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Candida albicans","conceptCode":"C77170","definition":"A species of diploid fungus in the phylum Ascomycota which is capable of mating but not of meiosis, and is a causal agent of opportunistic oral and genital infections in humans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D494-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"ZHANGW","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D751C8E1-827A-1B6B-E034-0003BA12F5E7","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Tetanus Toxoid","valueDescription":"Tetanus Toxoid","ValueMeaning":{"publicId":"2569060","version":"1","preferredName":"Tetanus Toxoid","longName":"2569060","preferredDefinition":"A substance that is derived from the toxin released by the bacterium that causes the disease tetanus.  It is used as a vaccine to prevent tetanus or to help boost the immune response to other vaccines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tetanus Toxoid Vaccine","conceptCode":"C2660","definition":"A preparation of formaldehyde-deactivated toxin isolated from the bacterium Clostridium tetani. Tetanus toxoid is used for booster injection and can stimulate the production of antitoxin antibodies. This agent may be used as an adjuvant in cancer vaccines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DAD1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D751C8E1-827B-1B6B-E034-0003BA12F5E7","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"REEVESD","dateModified":"2007-01-10","deletedIndicator":"No"},{"value":"PPD","valueDescription":"Purified Protein Derivative","ValueMeaning":{"publicId":"2585787","version":"1","preferredName":"Purified Protein Derivative","longName":"2585787","preferredDefinition":"A purified protein extract derived from the bacterium Mycobacterium tuberculosis. Intradermally-administered, PPD stimulates preprimed CD4 T cells in immunologically competent subjects previously exposed to the bacterium Mycobacterium tuberculosis; these activated CD4 T cells secrete various cytokines that attract granulocytes, monocytes, and macrophages in an inflammatory response known as delayed hypersensitivity. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Purified Protein Derivative","conceptCode":"C29329","definition":"A purified protein extract derived from the bacterium Mycobacterium tuberculosis. Intradermally-administered, PPD stimulates preprimed CD4 T cells in immunologically competent subjects previously exposed to the bacterium Mycobacterium tuberculosis; these activated CD4 T cells secrete various cytokines that attract granulocytes, monocytes, and macrophages in an inflammatory response known as delayed hypersensitivity. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26B7D4AD-FE8D-162C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"26B7D4AD-FEA5-162C-E044-0003BA3F9857","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-10","modifiedBy":"REEVESD","dateModified":"2007-01-10","deletedIndicator":"No"},{"value":"S. cerevisiae","valueDescription":"Saccharomyces cerevisiae","ValueMeaning":{"publicId":"2866899","version":"1","preferredName":"Saccharomyces cerevisiae","longName":"2866899","preferredDefinition":"A species of unicellular fungus used as a research subject and in baking and beer brewing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Saccharomyces cerevisiae","conceptCode":"C14271","definition":"A species of unicellular fungus used as a research subject and in baking and beer brewing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68DEDEC8-B8AB-2B09-E040-BB89AD436040","latestVersionIndicator":"Yes","beginDate":"2009-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68DEDEC8-B8C4-2B09-E040-BB89AD436040","beginDate":"2009-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-01","modifiedBy":"ONEDATA","dateModified":"2009-05-01","deletedIndicator":"No"},{"value":"Trichophyton","valueDescription":"Trichophyton","ValueMeaning":{"publicId":"3162578","version":"1","preferredName":"Trichophyton","longName":"3162578v1.00","preferredDefinition":"A genus of fungi in the phylum Ascomycota that includes those that cause tinea, athlete's foot, ringworm, and jock itch. Species in this genus are molds, characterized by the development of smooth-walled macro- and microconidia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trichophyton","conceptCode":"C127305","definition":"A genus of fungi in the phylum Ascomycota that includes those that cause tinea, athlete's foot, ringworm, and jock itch. Species in this genus are molds, characterized by the development of smooth-walled macro- and microconidia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95B582A0-EA74-9AA8-E040-BB89AD437354","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95B582A0-EA8D-9AA8-E040-BB89AD437354","beginDate":"2010-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-23","modifiedBy":"ONEDATA","dateModified":"2010-11-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D751C8E1-826A-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-05","modifiedBy":"REEVESD","dateModified":"2010-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"}]}],"AlternateNames":[{"name":"ATGN_TST_NM","type":"C3D Name","context":"CCR"},{"name":"ENGLISH","type":"CONTEXT NAME","context":"CCR"},{"name":"caBIG","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Antigen","type":"Preferred Question Text","description":"Antigen","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D751C8E1-827C-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-06","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"CCR CCMG approval of Released status on 4/21/2004.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}